10x Genomics (TXG) Return on Equity (2019 - 2026)

10x Genomics has disclosed Return on Equity across 8 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity came in at 0.0% for Q1 2026 at 10x Genomics, up from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2026 to a low of 0.0% in Q1 2024.
• The 5-year median for Return on Equity is 0.0% (2023), against an average of 0.0%.
• Peak annual rise in Return on Equity reached 1 bps in 2022, while the deepest fall reached 0 bps in 2022.
• 10x Genomics' Return on Equity stood at 0.0% in 2022, then slumped by 64 bps to 0.0% in 2023, then climbed by 26 bps to 0.0% in 2024, then surged by 78 bps to 0.0% in 2025, then surged by 49 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.